Huge Gainers, Fresh Ideas & More

Options Reviews:

More options updates are on the menu for this morning, with a recap of yesterday’s winners, as well as an update on one of our current running ideas.

From yesterday morning’s premarket report, we have the AMBA Weekly $112-115 Calls and the PLAN 09/17 $65-75 Calls, as well as some new highs in the SLQT 09/17 $7.50-10 Calls which we signaled on Tuesday morning.

AMBA Weekly $112-115 Calls
$112:
 7.30-19.96 (+173%)
$113: 7.60-19.00 (+150%)
$115: 3.00-17.60 (+487%)
_____

PLAN 09/17 $65-75 Calls
$65: 3.01-4.66 (+55%)
$70: .92-1.85 (+101%)
$75: .25-.50 (+100%)
_____

SLQT 09/17 $7.50-10 Calls
$7.50:
 1.80-3.47 (+93%)
$10: .40-1.25 (+212%)


Fresh Options Ideas:
CHPT Weekly $24-25 Calls
NTNX Weekly $37.50-40 Calls
SIG Weekly $80-90 Calls
CHWY Weekly $83-79 Puts


Medigus Ltd. MDGS – News Alert:

Another fresh PR from MDGS this morning, alluding to a new patent filing pertaining to Polyrizon’s cutting edge infection-resisting hydrogel technology. We’ve been tracking developments in MDGS’ interests, and Polyrizon has been one of the most active.

OMER, Israel, Sept. 02, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, has submitted an additional patent application to the United States Patent and Trademark Office for its innovative technology.

The invention generally pertains to the field of hydrogels that are capable to capture and contain biological assaults intrusion through the upper airways and eye cavities. Furthermore, the invention details a novel modality for a delivery system for drugs through the nasal mucosa that could get more drug into the body, and resides longer in the nasal cavity.

Recent pre-clinical data by Polyrizon, showed that its product candidate has the potential to reduce the risk of an infection with human coronavirus and may also prevent COVID-19 as well as Influenza Virus H1N1 and may potentially also treat additional Cold viruses. (>>Read Full PR HERE)


Metal Arts Co. Inc. MTRT  – Recap:

Lastly, we placed MTRT on watch in yesterday morning’s premarket report, and got instant results in the form of an enormous single-session push from this OTC play.

The stock traded up from a low of .5778 on the day, and reach a high of 5.05, for a whopping intraday move of 774% which came in on more than 18X the 30-day average volume.


Extended Watchlist:
PSTV, IPHA, SPRT, CHPT, TLSA, GSM, CCAJ, TLSS, TPTW, APTY, RHCO, HBRM

MDGS News, Big Options Gainers

More Sweet Options Success:

We’ve got another big time update on options gainers this morning. Not only did we hit on all three of our ideas from yesterday morning’s premarket report, but our longer-term idea in SPCE began to create some solid profit opportunities.

For yesterday’s premarket report our fresh ideas were the NTES Weekly $90-93 Calls, the ZM Weekly $310-300 Puts, and the SLQT 09/17 $7.50-10 Calls. Our specific targets in the SPCE chain from Monday’s report were the SPCE 10/01 $27-29 Calls.

Here are the ranges and total possible gains on all of those plays yesterday:

NTES Weekly $90-93 Calls
$90:
 3.40-7.70 (+126%)
$91: 3.23-6.70 (+107%)
$92: 2.75-5.35 (+94%)
$93: 2.05-4.24 (+106%)
_____

ZM Weekly $310-300 Puts
$310: 17.00-23.52 (+38%)
$305: 12.00-19.56 (+63%)
$300: 9.05-15.90 (+76%)
_____

SLQT 09/17 $7.50-10 Calls
$7.50:
 1.80-2.35 (+31%)
$10: .40-.60 (+50%)
_____

SPCE 10/01 $27-29 Calls
$27: 1.44-2.96 (+105%)
$28: 1.17-2.51 (+114%)
$29: .96-2.12 (+121%)


Fresh Options Ideas:
CONN 09/17 $25-27 Calls
AMBA Weekly $112-115 Calls
PLAN 09/17 $65-75 Calls


Medigus Ltd. MDGS – News Alert:

More news from MDGS hit the wires this morning, and we’re passing it along to you. For those who may have missed out, check out our MDGS Special Report from last week.

Today, the company has announced that one of its interests, Gix Media, is set to acquire a 70% stake in Cortex Group, a media tech firm, for roughly $11M.

OMER, Israel, Aug. 31, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that its affiliate Gix Internet (36.74% on a fully diluted bases) (TASE: GIX), a global marketing technology (MarTech) solutions company for online performance-based-marketing, announced that Gix Internet’s subsidiary, Gix Media signed a definitive agreement for the purchase of 70% at Cortex Group, an innovative media-tech company that has developed expertise in turning original content into a profit center through user traffic acquisition.(>>View Full PR)


Extended Watchlist:
RGBP, CYBL, ENZC, DXLG, TGGI, MTRT 

MDGS News, Options Plays & More

Medigus Ltd. MDGS – News Alert:

Our first order of business today is to go over the fresh news to hit the wires this morning for MDGS, One of the companies in which MDGS owns a controlling stake, is reporting that its Capture and Contain (C&C™) platform technology has been found effective in reducing the risk of infection with the H1N1 virus. Polyrizon has already reported similar results with coronavirus.

MDGS was the subject a special report we published on Monday morning. We’d suggest any of our readers who may have missed it, click here and go check it out. The stock has established higher lows each session this week, and it seems we timed the bottom with striking accuracy. Considering the frequency with which promising developments have been occurring for MDGS and its interests, like Polyrizon, we’re eager to see where this stock can go from here.
_____

OMER, Israel, Aug. 27, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, presented pre-clinical data showing that its Capture and Contain (C&C™) platform technology has the potential to reduce the risk of an infection with Influenza virus H1N1 and may potentially also treat additional Cold viruses.(>>Read Full PR)
_____

To Learn More about MDGS Please Visit:
Medigus.com/Investor-Relations


Options Review:

Two out of yesterday’s three fresh options ideas were quick strike post-earnings plays, the  ULTA Weekly $405-415 Calls and the CRM Weekly $262.50-270 Calls, and they both provided ample opportunity for solid daily gains.

ULTA Weekly $405-415 Calls
$405:
 2.66-8.58 (+222%)
$410: 2.51-6.76 (+169%)
$415: 1.88-8.72 (+364%)
______

CRM Weekly $262.50-270 Calls
$262.50: 7.74-12.95 (+67%)
$265: 5.92-10.55 (+78%)
$267.50: 4.60-8.10 (+76%)
$270: 3.31-5.92 (+79%)
_____

Fresh Options Ideas:
HIBB 09/17 $100-105 Calls
GPS Weekly $27-28.50 Calls*
WDAY Weekly $255-270*

*Please don’t attempt to trade weekly options on a Friday unless you are an experienced trader with access to disposable funds!


Extended Watchlist:
SPRT, NURO, RNXT, CEMI, NNA, PRFX, CLNV, BRBP, ICOA, SRCO, BRNE

Interesting Ground Floor NASDAQ Opportunity

Medigus Ltd. (NASDAQ: MDGS) – Special Focus:

We’re excited to be presenting another focus report this morning, where we’ll be going a bit more in-depth than usual in looking at this innovative small cap technology company trading on the NASDAQ that we feel is loaded with future potential. Medigus is a well-diversified conglomerate that is actively pursuing goals in the medical, digital commerce, and electric vehicle market spaces.

One would be hard-pressed to find a more relevant grouping of interests better suited to the realities of 2021 and beyond. We’ll break these down by sector to give readers a more comprehensive understanding of all of the irons that MDGS currently has in the fire (You may click each link to learn more):

Medical: 

Scoutcam – World’s smallest medical device camera with FDA clearance that meets several key surgical needs, including illumination irrigation and single-use design. This patented technology can be custom tailored for use in a variety of industries such as Aerospace, Research and Defense.

PolyrizonPrivate company in which MDGS is a 33% stakeholder, which is developing proprietary technology that protects against biological threats and external pathogens. Recent pre-clinical studies show that its technology has the potential to reduce the risk of coronavirus infection.
_____

Digital Commerce:

Gix – Innovative AI technology that offers advanced customizable marketing solutions that maximize users’ online exposure to specifically targeted audiences/prospective clientele.

Eventer – Platform for the creation, marketing and managing of both virtual and real world. Enables customers, both businesses and individuals to produce, promote and sell tickets to these events.

Smart Repair Pro – Online stores purveying various consumer goods via Amazon (In the US and Germany, the first and second largest Amazon marketplaces in the world.
_____

Electric Vehicle (EV) Market: 

Charging Robotics – Developing on-demand autonomous charging system for both manned and unmanned EV’s, with cutting-edge wireless power transfer (WPT) technology. Proof of concept recently attained (click link for more info).

Revoltz – Electric micro-mobility vehicles specifically for “last mile” delivery of consumer goods. Based on customer needs such as handling a full work day on a single charge, Hop-on-Hop-off modes, and off-road capabilities.

(PLEASE NOTE: Apart from Charging Robotics, of which MDGS is the sole owner, the company owns a controlling interest in the remainder of the above-mentioned subsidiaries)

As you can plainly see, we are not off-base in our characterization of MDGS being highly diversified into a range of future-forward market spaces. It’s one of the primary factors that we find attractive about this particular stock. Given that it is currently trading at a relative bottom, we can’t imagine a better time to entertain the prospect of taking a long-term position. 


MDGS CHART: 

(Placeholder image…Real-time assessment and chart snapshot to be generated on morning of release)


RECENT MDGS NEWS:

– Polyrizons innovative proprietary technology found effective against coronavirus in a pre-clinical study – July 23rd

– Medigus Board of Directors Decides to Promote a $2 Million Buyback Program – July 28th

– Charging Robotics Successfully Completes a Proof of Concept for its Electric Vehicle Wireless Charging Robot – July 30th


To Learn More about MDGS Please Visit:
Medigus.com/Investor-Relations

RTTR Pops, Options Recaps & More

Ritter Pharmaceuticals Inc. RTTR

We were looking for a big start to the week, which we did get with our options ideas on Monday, but we also included RTTR in that report, and yesterday the stock really went for a ride.

From a low of .332 Monday morning, to yesterday’s new high of .74 it marks a two-day upswing and total possible gains of 123%


Options Updates

We also formulated several options ideas in yesterday morning’s premarket report, and were flushed with solid opportunities to profit in 3 out of our 4 target ranges. Here are the moves made by those contracts on the day:

CHGG 05/15 $45-55 Calls
$45: 
8.00-16.19 (+102%)
$50: 4.00-12.00 (+200%)
$55: 1.36-7.89 (+480%)
_____

PTON Weekly $34-35 Calls*
$34: 
2.96-4.00 (+35%)
$35: 2.41-3.50 (+45%)

*Based on premarket activity, we expect to see the gains here increased today, so keep an eye peeled.
_____

SPY 05/06 $285-288 Calls
$285: 2.93-4.83 (+65%)
$286: 2.36-4.04 (+71%)
$287: 1.83-3.30 (+80%)
$288: 1.37-2.64 (+93%)


Fresh Options Ideas:
CVS Weekly $62-63 Calls
EA Weekly $120-115 Puts
INMD 05/15 $25-30 Calls
CLVS Weekly $8-8.50 Calls


Extended Watchlist:
MDGS, ALA, POAI, VNTR, CARS, MELI,

Get Our FREE Daily Reports!